Evi Comploj

Improving Selection Criteria for Early Cystectomy in High-Grade T1 Bladder Cancer: A Meta-Analysis of 15,215 Patients

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update

The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study

Urinary Cytology and Quantitative BTA and UBC Tests in Surveillance of Patients with pTapT1 Bladder Urothelial Carcinoma

Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis

External validation of the pathological nodal staging score in upper tract urothelial carcinoma: A population-based study

Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice

Investigations of Urothelial Cells Seeded on Commercially Available Small Intestine Submucosa

Surveillance for Recurrent Bladder Cancer Using a Point-of-Care Proteomic Assay

Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy

ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology

An overview of tissue and whole organ decellularization processes

Effects of Comorbidities on Outcomes of Patients With Intraductal Papillary Mucinous Neoplasms

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa–pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

Bladder cancer biomarkers: current developments and future implementation

Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer

Diagnosis of urothelial carcinoma from urine

EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines

Bladder cancer

Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer

Diagnostic biomarkers in non-muscle invasive bladder cancer

UroVysion FISH test for detecting urothelial cancers: Meta-analysis of diagnostic accuracy and comparison with urinary cytology testing

Sarcopenia

Epidemiology and Risk Factors of Urothelial Bladder Cancer

Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines

Effect of Smoking on Outcomes of Urothelial Carcinoma: A Systematic Review of the Literature

Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes

Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus

Treatment Options Available for Bacillus Calmette-Guérin Failure in Non–muscle-invasive Bladder Cancer

HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC)

Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas

Urinary Markers in Bladder Cancer

Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer

Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer

Cytology and Urinary Markers for the Diagnosis of Bladder Cancer

Bladder Cancer

Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma

Prospective Validation of the Clinical Usefulness of Reflex Fluorescence In Situ Hybridization Assay in Patients With Atypical Cytology for the Detection of Urothelial Carcinoma of the Bladder

Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma

The MicroRNA Spectrum in 12 Body Fluids

Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates

Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma

uCyt+/ImmunoCyt and cytology in the detection of urothelial carcinoma

Multiprobe fluorescence in situ hybridisation: prognostic perspectives in superficial bladder cancer

Effect of intravesical instillation on performance of uCYT+ test

Comparison of Complications in Three Incontinent Urinary Diversions

Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder

Liquid‐based cytology as a tool for the performance of uCyt+^TM and Urovysion^® Multicolour‐FISH in the detection of urothelial carcinoma

Prediction of True Nodal Status in Patients with Pathological Lymph Node Negative Upper Tract Urothelial Carcinoma at Radical Nephroureterectomy

Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro‐ureterectomy

uCyt+/ImmunoCyt™ in the detection of recurrent urothelial carcinoma

Perforation during TUR of bladder tumours influences the natural history of superficial bladder cancer

The dilemma of cystectomy in old-old and oldest-old patients

Four Years Experience in Bladder Preserving Management for Muscle Invasive Bladder Cancer

Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder

Docetaxel, with or without estramustine phosphate, as first‐line chemotherapy for hormone‐refractory prostate cancer: results of a multicentre, randomized phase II trial

Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder

uCyt+ test: Alternative to cystoscopy for less-invasive follow-up of patients with low risk of urothelial carcinoma

Comorbidity and Performance Indices as Predictors of Cancer-Independent Mortality But Not of Cancer-Specific Mortality After Radical Cystectomy for Urothelial Carcinoma of the Bladder

Intermediate-risk urothelial carcinoma: an unresolved problem?

Impact of Smoking on Outcomes of Patients with a History of Recurrent Nonmuscle Invasive Bladder Cancer

Sarcopenia as a comorbidity‐independent predictor of survival following radical cystectomy for bladder cancer

The value of the ImmunoCyt/uCyt+ test in the detection and follow-up of carcinoma in situ of the urinary bladder.

Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer?

601 Role of conventional cytology in the treatment of upper tract urothelial carcinoma (OSS-UTUC): Results from the multi-institutional organ-sparing-UTUC collaboration